Eli Lilly and Co. plans to bolster its domestic medicine production with a $27B investment in four new U.S. pharmaceutical manufacturing sites, bringing its total capital commitment to future expansion to more than $50B.
The company is negotiating with several states on locations for the new sites and will be taking proposals through March 12, it said in a press release.
Lilly expects to create more than 3,000 jobs for highly skilled workers at the four sites, including engineers, scientists, operations personnel and lab technicians. The company also anticipates it could create nearly 10,000 construction jobs during development.
“We are not just building facilities,” said Edgardo Hernandez, executive vice president and president of Lilly Manufacturing Operations, in the release. “We are creating a future where American innovation leads the world in pharmaceutical manufacturing, requiring a highly skilled workforce prepared to shape the future of health care.”...
Lilly expects to create more than 3,000 jobs for highly skilled workers at the four sites, including engineers, scientists, operations personnel and lab technicians. The company also anticipates it could create nearly 10,000 construction jobs during development.
“We are not just building facilities,” said Edgardo Hernandez, executive vice president and president of Lilly Manufacturing Operations, in the release. “We are creating a future where American innovation leads the world in pharmaceutical manufacturing, requiring a highly skilled workforce prepared to shape the future of health care.”...
Lilly announces $3 billion expansion of its recently acquired manufacturing facility in Wisconsin
...moreRSK: And I believe one of these sites is in SE WIsconsin on or near the old FoxxConn site.
Share this article on your social outlets
Our Sponsors
- - Volume: 25 - WEEK: 10 Date: 3/5/2025 4:10:58 PM -